PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION

Clinical trials for PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION explained in plain language.

Never miss a new study

Get alerted when new PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION trials appear

Sign up with your email to follow new studies for PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Vitamin-Based treatment tested for rare brain disorder

Disease control Completed

This study tested whether a vitamin metabolite could help control Pantothenate Kinase-Associated Neurodegeneration (PKAN), a rare genetic brain disorder. Researchers enrolled 77 people with PKAN across North America to check if the treatment was safe and if it affected disease ma…

Matched conditions: PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION

Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION

Get alerted when new PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION trials appear

Vitamin-Based treatment tested for rare brain disorder